- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04944667
Use of Virtual Reality for Procedural Planning of Transcatheter Aortic Valve Replacement
March 8, 2022 updated by: Eduard Permanyer, Centro Medico Teknon
Use of Virtual Reality for Procedural Planning of Transcatheter Aortic Valve Replacement (TAVR)
This study sought to evaluate the impact of Virtual Reality (VR) tools in procedural planning of transcatheter aortic valve replacement (TAVR).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A prospective study involving 11 patients referred for TAVR was conducted.
A multidetector computed tomography (MDCT) was used to acquire and segment the anatomy of the access route and landing zone.
From the information obtained with the MDCT in DICOM format, the investigators built a virtual platform (VisuaMed, Teacher Team.
Valencia.
Spain) that contains all the clinical information of the patients and a virtualized model of their anatomy.
Wearing VR devices, the professional was able to "walk inside " the anatomy in an interactive and immersive way.
Decisions after the evaluation of routine clinical images were compared with those after experience with VR models and intraprocedural findings.
Study Type
Interventional
Enrollment (Actual)
11
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Barcelona, Spain, 08022
- CentroMT (Centro Médico Teknon)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Severe aortic stenosis considered for TAVR procedure at a single Institution
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: TAVR standard
TAVR planning evaluated without VR and TAVR planning after VR analysis
|
TAVR planning without VR vs after VR
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
TAVR procedure planning (prosthesis size, implant technique requirements, potential risks)
Time Frame: Baseline
|
Does the TAVR procedure planning change after VR?
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2020
Primary Completion (Actual)
May 31, 2021
Study Completion (Actual)
May 31, 2021
Study Registration Dates
First Submitted
June 9, 2021
First Submitted That Met QC Criteria
June 21, 2021
First Posted (Actual)
June 29, 2021
Study Record Updates
Last Update Posted (Actual)
March 22, 2022
Last Update Submitted That Met QC Criteria
March 8, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Cardiac Surgery CentroMT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Stenosis, Severe
-
Yonsei UniversityRecruitingSevere Aortic Stenosis or Severe Aortic RegurgitationKorea, Republic of
-
Abbott Medical DevicesActive, not recruitingSevere Aortic Stenosis | Symptomatic Degenerative Aortic StenosisSpain, Italy, United Kingdom, Germany, Switzerland, Czechia, Australia, Belgium, Poland
-
Ningbo Jenscare Biotechnology Co., Ltd.UnknownAortic Regurgitation | Severe Aortic Stenosis
-
Ceric SàrlEuropean Cardiovascular Research Center; Biosensors InternationalNot yet recruitingAortic Stenosis, Severe
-
Yonsei UniversityRecruiting
-
Edwards LifesciencesRecruiting
-
Edwards LifesciencesCompletedSevere Aortic StenosisSpain, Italy, Canada, Belgium, Greece, Germany, Austria, United Kingdom, Finland, Denmark, France, Switzerland, Israel, Poland, South Africa, Czechia, Netherlands, Norway
-
Opsens, Inc.CompletedSevere Aortic StenosisSpain
-
Medtronic Bakken Research CenterCompletedSevere Aortic StenosisItaly, Israel, Germany, Netherlands, Greece, France, Switzerland, United Kingdom, Portugal, Denmark, Belgium, Colombia
-
Second Affiliated Hospital, School of Medicine,...RecruitingSevere Aortic StenosisChina
Clinical Trials on TAVR planning
-
Niguarda HospitalRecruitingAortic Valve Stenosis | Transcatheter Aortic Valve ReplacementItaly
-
Abbott Medical DevicesCompletedAortic Valve StenosisGermany, Netherlands, Italy, Switzerland, Denmark
-
Edwards LifesciencesActive, not recruitingSymptomatic Severe Aortic StenosisUnited States
-
IRCCS Policlinico S. DonatoCompletedFailed Transcather Aortic ValveItaly
-
University of UlmCompletedPM Implantation After TAVRGermany
-
Michele De BonisCompletedAortic StenosisDenmark, Hungary, Italy
-
IRCCS Policlinico S. DonatoNot yet recruiting
-
Duk-Woo Park, MDCardioVascular Research Foundation, KoreaRecruitingHeart Valve Diseases | Aortic Valve InsufficiencyKorea, Republic of, United States, China
-
IHF GmbH - Institut für HerzinfarktforschungYale University; Boston Scientific GroupActive, not recruiting
-
Medstar Health Research InstituteMedtronic CardiovascularActive, not recruiting